2004
DOI: 10.1016/j.phrs.2004.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
44
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(48 citation statements)
references
References 18 publications
2
44
0
Order By: Relevance
“…While high doses of 5-FU exposure result in drastic and rapid cytotoxic effects, low doses, which correspond to doses used in the clinic [34, 35], promote delay in cytotoxicity. In particular, cells exposed to 10 μM of 5-FU for 24 hrs remain viable and metabolically active, and keep their capacity to synthesize proteins.…”
Section: Discussionmentioning
confidence: 99%
“…While high doses of 5-FU exposure result in drastic and rapid cytotoxic effects, low doses, which correspond to doses used in the clinic [34, 35], promote delay in cytotoxicity. In particular, cells exposed to 10 μM of 5-FU for 24 hrs remain viable and metabolically active, and keep their capacity to synthesize proteins.…”
Section: Discussionmentioning
confidence: 99%
“…Although 5-FU was shown to have substantial antibacterial effects, the tested concentrations in these studies were much higher than what is usually present in vivo. Notwithstanding the fact that after an intravenous bolus injection with 5-FU, plasma concentrations in cancer patients can reach some hundred micromolars, the plasma levels eventually drop to 15-30 µM after 30 min and to 0 µM after 2 h (Casale et al, 2004;Kosovec et al, 2008), owing to the short half-life time (6-22 min) of 5-FU (Bocci et al, 2000). In the case of continuous infusion with 5-FU, the plasma concentrations are much lower, ranging from 3 to 10 µM and kept for a longer time period (24 h) (Joulia et al, 1999;Takimoto et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…For these reasons, some inter-patient differences in terms of toxicity and efficacy can be expected based on individual pharmacokinetic parameters, especially in the area under the time vs. concentration curve (AUC) Casale et al, 2004). Another problem with 5-FU therapy is its toxicity to the bone marrow and the gastrointestinal tract (Tanaka et al, 2000;Lai, Guo, 2011).…”
Section: Introductionmentioning
confidence: 99%